About this trial
To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery
Eligibility criteria
Qualifiers
Patients undergoing breast cancer surgery with general anesthesia in the hospital;
American Society of Anesthesiologists (ASA) classification I-II;
Women aged 18-55 years;
No history of chronic insomnia;
Disqualifiers
Those who do not meet the aforementioned inclusion criteria;
A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);
A history of sleep disorders and psychiatric history;
Inability to receive thumb-tack needle treatment.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
The First Affiliated Hospital of Xiamen University
Lead sponsor
Fujian Medical University
Sponsor institution